Valeria Giandomenico Selected Research

Ma2 antigen

12/2010	Paraneoplastic antigen Ma2 autoantibodies as specific blood biomarkers for detection of early recurrence of small intestine neuroendocrine tumors.
2/2009	Novel markers for enterochromaffin cells and gastrointestinal neuroendocrine carcinomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Valeria Giandomenico Research Topics

Disease

13	Neoplasms (Cancer) 01/2017 - 01/2005
8	Neoplasm Metastasis (Metastasis) 10/2017 - 04/2007
6	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2015 - 01/2010
6	Carcinoid Tumor (Carcinoid) 12/2013 - 01/2005
2	Prostatic Neoplasms (Prostate Cancer) 10/2017 - 08/2003
2	Neuroendocrine Carcinoma 02/2013 - 02/2009
1	Carcinogenesis 05/2013
1	Necrosis 01/2012
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2010
1	Testicular Neoplasms (Testicular Cancer) 01/2005
1	Adenocarcinoma 08/2003

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2017 - 08/2003
5	Chromogranin AIBA 01/2017 - 04/2007
5	Biomarkers (Surrogate Marker)IBA 05/2013 - 02/2009
4	Odorant Receptors (Odorant Receptor)IBA 10/2017 - 02/2009
3	MicroRNAs (MicroRNA)IBA 01/2015 - 01/2010
2	AntibodiesIBA 01/2017 - 12/2010
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 09/2015 - 01/2015
2	Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA 02/2013 - 03/2008
2	LigandsIBA 01/2012 - 02/2009
2	Ma2 antigenIBA 12/2010 - 02/2009
2	Serotonin (5 Hydroxytryptamine)IBA 02/2009 - 01/2005
2	AntigensIBA 03/2008 - 01/2005
1	galleinIBA 10/2017
1	Norisoprenoids (Irones)IBA 10/2017
1	Cell-Penetrating PeptidesIBA 01/2017
1	Immune Checkpoint InhibitorsIBA 01/2017
1	Sunitinib (Sutent)FDA Link 01/2017
1	Chimeric Antigen ReceptorsIBA 01/2017
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2017
1	Somatostatin Receptors (Somatostatin Receptor)IBA 12/2013
1	pentetreotide (OctreoScan)FDA Link 12/2013
1	ParaffinIBA 12/2013
1	RNA (Ribonucleic Acid)IBA 05/2013
1	Hormones (Hormone)IBA 01/2013
1	Blood Proteins (Serum Proteins)IBA 01/2013
1	Growth Differentiation Factor 15IBA 01/2012
1	epithelial membrane protein-1IBA 01/2012
1	Octreotide (Sandostatin)FDA LinkGeneric 01/2012
1	rho GTPase-activating proteinIBA 01/2012
1	Annexin A1IBA 01/2012
1	Transforming Growth Factor-beta Type II ReceptorIBA 01/2012
1	Coloring Agents (Dyes)IBA 12/2010
1	AutoantibodiesIBA 12/2010
1	AMPA 2 glutamate receptor ionotropicIBA 02/2009
1	CXC ChemokinesIBA 02/2009
1	antineoplaston A10 (A 10)IBA 02/2009
1	Transcription Factors (Transcription Factor)IBA 02/2009
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 02/2009
1	SerpinsIBA 02/2009
1	Peptides (Polypeptides)IBA 03/2008
1	Messenger RNA (mRNA)IBA 03/2008
1	AutoantigensIBA 03/2008
1	Tryptophan HydroxylaseIBA 03/2008
1	EpitopesIBA 03/2008
1	CDX2 Transcription FactorIBA 03/2008
1	HLA-A*02:01 antigenIBA 03/2008
1	SurvivinIBA 01/2005
1	TARPIBA 08/2003
1	gamma-delta T-Cell Antigen Receptors (T-Cell Receptor delta-Chain)IBA 08/2003

Therapy/Procedure

3	Immunotherapy 01/2017 - 01/2005
3	Therapeutics 12/2013 - 01/2005
2	Lasers (Laser) 05/2013 - 02/2009
1	Intraperitoneal Injections 10/2017
1	Semiconductors 01/2014
1	Radioimmunotherapy 02/2013